Most lately, it's been discovered that conolidine and the above derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor acts as being a scavenger https://carlx691yuo0.mdkblog.com/profile